Venus Remedies

Venus Remedies Current Assets

The Current Assets of Venus Remedies (VENUSREM.NS) as of Nov 10, 2026 is 2.84 B INR. In the previous year, Current Assets was 5.23 B INR — a change of -45.71% (lower).

Current Assets

2.84 BINR

YoY

-45.71%

Last updated:

Current Assets of Venus Remedies is 2026 2.84 B INR. Current Assets of Venus Remedies was 2025 5.23 B INR. It decreases by -45.71% lower compared to the previous year.

The Venus Remedies Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
2.94 B INR
Jan 1, 2020
3.12 B INR
Jan 1, 2021
2.57 B INR
Jan 1, 2022
2.72 B INR
Jan 1, 2023
3.71 B INR
Jan 1, 2024
4.27 B INR
Jan 1, 2025
5.23 B INR
Jan 1, 2026
2.84 B INR
The Venus Remedies Current Assets history
YEARCurrent AssetsYoY
2.84 BINR-45.71%
5.23 BINR+22.41%
4.27 BINR+15.18%
3.71 BINR+36.04%
2.72 BINR+5.88%
2.57 BINR-17.42%
3.12 BINR+6.04%
2.94 BINR+12.83%
2.60 BINR+13.90%
2.29 BINR-6.95%
2.46 BINR-15.53%
2.91 BINR-12.51%
3.33 BINR+46.93%
2.26 BINR-6.23%
2.41 BINR+74.35%
1.38 BINR+16.59%
1.19 BINR+15.18%
1.03 BINR+60.75%
641.40 MINR+65.96%
386.48 MINR+42.76%
270.71 MINR+71.77%
157.60 MINR+21.42%
129.80 MINR+4.85%
123.80 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Venus Remedies Stock analysis

What does Venus Remedies do? Venus Remedies Ltd. manufactures and trades pharmaceutical products, focusing on injectables, tablets, and topical preparations for therapeutic segments including anti-infective, oncology, skin and wound care, and pain management. The company's brands such as Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, Ventaful, and Nervolize cater to critical care and super specialty markets. Its product portfolio addresses antimicrobial resistance (AMR), oncology, neurology, anticoagulants, and herbal solutions, serving medicine, surgery, neuro, and orthopedics. The firm operates in the Pharmaceutical Formulation segment with three manufacturing facilities. The company sells its pharmaceutical products to healthcare providers and institutions globally, targeting critical care and super specialty segments. Brands like Potentox and Vancoplus Combi are positioned for antimicrobial resistance (AMR) solutions, while Neurotol and Trois serve neurology and orthopedics. Supime and Zydotum focus on pain management and skin care, and Septiloc and Mucomelt address anticoagulants and wound care. Venus Remedies' formulations include injectables, tablets, and topical preparations for diverse therapeutic needs. Venus Remedies Ltd. generates revenue through the sale of its branded pharmaceutical products, including injectables, tablets, and topical preparations. The company's product lines target specific therapy areas such as AMR, oncology, skin and wound care, and pain management, with brands like Ventaful and Nervolize supporting neurology and anticoagulant markets. The firm's global reach in injectable manufacturing and focus on super specialty segments drive its market positioning within the Pharmaceutical Formulation segment. Venus Remedies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Venus Remedies stock

Current Assets of Venus Remedies is 2.84 B INR in 2026.

Current Assets of Venus Remedies changed from 5.23 B INR to 2.84 B INR, representing a -45.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Venus Remedies since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Venus Remedies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Venus Remedies

All Key Metrics — Venus Remedies